Simplify Drug Manufacturing license attestation process
Reform ID		F269
Description		The existing manual attestation requirement by DRAP for Drug Manufacturing Licenses used in the import of APIs is redundant, time-consuming, and imposes unnecessary compliance costs on licensed manufacturers. The process lacks a clearly defined legal and regulatory basis, creating avoidable procedural delays and administrative burden. This requirement hinders operational efficiency and may delay imports of essential pharmaceutical raw materials without adding substantive regulatory value.
Department		Drug Regulatory Authority of Pakistan - DRAP
Jurisdiction / Location		Federal - Entire Pakistan
Sector		Pharmaceuticals and Healthcare
Start Date		18-08-2025
Target Deadline		19-11-2025
Date Enacted
Implementation Status		Completed
Progress		100%
CCORR Direction		Simplify & Digitize
Cost Savings PKR (Mil.)
Evidence